What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort?
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
During the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among Hispanic Americans toward the coronavirus and a generational gap in willingness to get a potential vaccine.
This brief provides an overview of key issues to consider for reaching noncitizen immigrants as part of COVID-19 vaccination efforts.
With the pandemic taking a heavy toll among older Americans, the Centers for Disease Control and Prevention and most states have placed a high priority on vaccinating residents and staff of long-term care facilities.
As the first doses of the new COVID-19 vaccine are delivered to health care workers and other early recipients, many Americans are eager to know not only when the vaccine will be available to them but also whether they will be able to get it at no cost.
This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.
The brief provides an overview of how vaccines are reimbursed and covered across government programs and different types of health insurance in the United States. It coverage regulations specific to COVID-19 vaccine(s).
This analysis from the KFF COVID-19 Vaccine Monitor explores the public's response to the news about the omicron variant of coronavirus, and finds that while it may convince vaccinated adults to get their COVID-19 booster vaccine, unvaccinated adults are largely unmoved by the news.
© 2025 KFF